InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Ginascol John F, Executive. Officer active across 1 company, notably Abbott Laboratories. In total, 8 disclosures have been published. Split: 0 buy · 1 sell. Total volume traded: €1.2m. Activity tracked since 3 June 2021. The latest transaction was filed on 28 February 2023 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Ginascol John F
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
6,859 shares@ US$99.779.7% of flowCommon shares without par valueSEC:0001415889-23-003908:0
14,270 shares0Common shares without par valueSEC:0001415889-23-003053:0
11,000 shares@ US$112.3217.6% of flowCommon shares without par valueSEC:0001415889-22-012600:0
1,768 shares@ US$117.510.0001% mcap4.0% of flowCommon shares without par valueSEC:0001415889-22-006223:0
5,876 shares@ US$122.4113.8% of flowCommon shares without par valueSEC:0001415889-22-002193:0
17,247 shares0Common shares without par valueSEC:0001415889-22-001738:0
45,709 shares@ US$47.0039.7% of flowCommon shares without par valueSEC:0001415889-21-004998:0
1,768 shares@ US$106.903.3% of flowCommon shares without par valueSEC:0001415889-21-002830:0
8 of 8 declarations
About Ginascol John F
John F. Ginascol serves as Executive Vice President at ABBOTT LABORATORIES. He is responsible for implementing operational strategies to enhance the company's efficiency. His role is essential to ensure Abbott remains competitive in the healthcare sector.
